These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36227781)

  • 1. Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome.
    Waseem MR; Shin A; Siwiec R; James-Stevenson T; Bohm M; Rogers N; Wo J; Waseem L; Gupta A; Jarrett M; Kadariya J; Xu H
    Clin Transl Gastroenterol; 2023 Jan; 14(1):e00541. PubMed ID: 36227781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
    Calderon G; Patel C; Camilleri M; James-Stevenson T; Bohm M; Siwiec R; Rogers N; Wo J; Lockett C; Gupta A; Xu H; Shin A
    J Clin Gastroenterol; 2022 Mar; 56(3):234-242. PubMed ID: 33780215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.
    Ringel-Kulka T; Choi CH; Temas D; Kim A; Maier DM; Scott K; Galanko JA; Ringel Y
    Am J Gastroenterol; 2015 Sep; 110(9):1339-46. PubMed ID: 26303129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Sun Q; Jia Q; Song L; Duan L
    Medicine (Baltimore); 2019 Feb; 98(7):e14513. PubMed ID: 30762787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
    Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.
    Kamp KJ; Cain KC; Utleg A; Burr RL; Raftery D; Luna RA; Shulman RJ; Heitkemper MM
    Biol Res Nurs; 2021 Jan; 23(1):65-74. PubMed ID: 32666807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.
    Camilleri M; Klee EW; Shin A; Carlson P; Li Y; Grover M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G13-26. PubMed ID: 24200957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: Relations to subtype.
    Teige ES; Hillestad EMR; Steinsvik EK; Brønstad I; Lundervold A; Lundervold AJ; Valeur J; Hausken T; Berentsen B; Lied GA
    Neurogastroenterol Motil; 2024 Sep; 36(9):e14854. PubMed ID: 38946176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids.
    Sagar NM; Duboc H; Kay GL; Alam MT; Wicaksono AN; Covington JA; Quince C; Kokkorou M; Svolos V; Palmieri LJ; Gerasimidis K; Walters JRF; Arasaradnam RP
    Sci Rep; 2020 Nov; 10(1):20436. PubMed ID: 33235223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
    Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.